Torrent Pharmaceuticals Assigned Crisil ESG 66 & Core 74

Torrent Pharmaceuticals Limited has submitted a regulatory disclosure to the BSE Limited and the National Stock Exchange of India Ltd.

The disclosure is an intimation made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026.

The company notified the exchanges that Crisil ESG Ratings & Analytics Limited, a SEBI registered ESG Rating Provider, has independently assigned it two ratings: a 'Crisil ESG 66' and a Core ESG rating of 'Crisil Core ESG 74'.

The letter was signed by Chintan M. Trivedi, Company Secretary, and was digitally signed on 17th July, 2026 at 21:59:32 +05'30'.